Analyst Edward Nash of Canaccord Genuity maintained a Buy rating on Pliant Therapeutics (PLRX – Research Report), retaining the price ...

Idiopathic pulmonary fibrosis (IPF), the most common phenotype of IIPs, has a prognosis that is influenced by a number of ...

周一，H.C. Wainwright重申了对Pliant Therapeutics (NASDAQ:PLRX)股票的买入评级，目标价维持在$38.00。该公司的乐观态度源于bexotegrast治疗特发性肺纤维化(IPF)的BEACON-IPF临床试验的进展。该试验正按计划进行，预计患者招募将在2025年第一季度结束。 BEACON-IPF试验是一项为期52周的研究，旨在评估bexotegrast ...

The primary focus is on the company’s bexotegrast, an αvß6/αvß1 integrin inhibitor, which is being developed for the treatment of idiopathic pulmonary fibrosis (IPF). The enrollment for the Phase 2b/3 ...

近日，备受全球华人瞩目的2024年福布斯全球华人精英TOP 100榜单正式揭晓，康蒂尼药业董事会主席罗楹凭借其*的领导力和在医药创新领域的杰出贡献成功入选。这份荣誉不仅彰显了罗楹个人的*成就与不懈努力，更凸显了康蒂尼药业在医药行业的*地位和深远影响。

“This will significantly modernise IPF’s Brisbane PDC capability, enabling us to meet our customers’ expectations well into the future. “The decision to relocate the PDC allows us to progress our ...

Walker announced earlier in the month that he was retiring from radio after 58 years due to ill health, having been previously diagnosed with idiopathic pulmonary fibrosis (IPF). After playing Johnny ...

周五，Stifel重申了对Pliant Therapeutics (NASDAQ:PLRX)股票的买入评级，目标价保持在32.00美元。该投资公司的前景仍然乐观，因为Pliant Therapeutics正在推进其Bexotegrast治疗特发性肺纤维化(IPF)的2/3期BEACON-IPF试验。IPF是一种以肺部瘢痕形成为特征的疾病，目前亟需有效的治疗方法。 预计该试验的2b期部分将在2025 ...

Se og Hor reported a sighting of the royal boarding a flight from Gardermoen to London at 1pm with Marius Borg Høiby, 27, who ...

Good afternoon, and welcome to the MannKind Corporation third quarter 2024 financial results earnings call. As a reminder, ...

BEACON-IPF Phase 2b trial on track for full enrollment in the first quarter of 2025 with data anticipated in mid-2026 SOUTH ...

Three major industry organisations are planning to merge and form a single body to represent the property sector.